79Au Gold-Based Metallotherapeutics: Use and Potential

Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine

Volumn , Issue , 2005, Pages 507-527

  Yei Ho, Soo ^a   Tiekink, Edward R T ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Chemical reactivity of gold; First generation gold compounds; Gold in medicine; Gold based drug Auranofin; Gold gold distance; Green gold; Non steroidal anti inflammatory drugs (NSAIDS); Water soluble gold based drugs

Indexed keywords

EID: 84889419881     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470864052.ch26     Document Type: Chapter

References (101)

1. http://www.webelements.com/webelements/text/Au/index.html.
2. R.J. Puddephatt, The Chemistry of Gold, Elsevier Scientific Publishing Company, New York, 1980.
3. J. Kordis, K.A. Gingerich and R.J. Seyse, J. Chem. Phy., 61, 5114-5121 (1974).
4. J. Donohue, The Structures of the Elements, Wiley, New York, 1974.
5. H. Schmidbaur, Interdis. Sci. Rev., 17, 213-220 (1992).
6. H. Schmidbaur, Gold Bull., 23, 11-21 (1990).
7. H. Schmidbaur, Gold Bull., 33, 3-10 (2000).
8. H. Schmidbaur, Nature (London), 413, 31-33 (2001).
9. P. Schwerdtfeger, P.D.W. Boyd, A.K. Burrell et al., Inorg. Chem., 29, 3593-3607 (1990).
10. P. Pyykkö, Chem. Rev., 97, 597-636 (1997).
11. P. Pyykkö, Angew. Chem. Int. Ed., 41, 3573-3578 (2002).
12. S.A. Cotton, Chemistry of Precious Metals, Blackie Academic & Professional, London (1997).
13. H. Schmidbaur and R. Franke, Chem. Ber., 105, 2985-2997 (1972).
14. P.L. Bellon, M. Manassero and M. Sansoni, Ric. Sci., 39, 173-175 (1969).
15. F. Klanberg, E.L. Muetterties and L.J. Guggenberger, Inorg. Chem., 7, 2272-2278 (1968).
16. R.L. Rich and H. Taube, J. Phys. Chem., 58, 6-11 (1954).
17. H. Schmidbauer, J.R. Mandl, A. Frank and G. Huttner, Chem. Ber., 109, 466-472 (1976).
18. J.G.M. Van Rens, M.P.A. Viegers and E. De Boer, Chem. Phys. Lett., 28, 104-108 (1974).
19. R.J. Charlton, C.M. Harris, H. Patil and N.C. Stephenson, Inorg. Nucl. Chem. Lett., 2, 409-414 (1966).
20. W.T. Robinson and E. Sinn, J. Chem. Soc., Dalton Trans., 726-731 (1975).
21. G.J. Higby, Gold Bull., 15, 130-140 (1982).
22. E.R.T. Tiekink and M.W. Whitehouse, Chem. Aust., 57, 346-348 (1990).
23. S.P. Fricker, Medicinal chemistry of organogold compounds, in The Chemistry of Organic Derivatives of Gold & Silver, S. Patai and Z. Rappoport (Eds), John Wiley & Sons Ltd, New York, 1999.
24. R. Koch, Dtsch. Med. Wochenschr., 16, 756-757 (1890).
25. W. Unverzagt, Dtsch. Med. Wochenschr., 53, 1985-1986 (1927).
26. A. Macdowell, Am. Rev. Tuberculosis, 25, 252-284 (1932).
27. B. Merchant, Biologicals, 26, 49-59 (1998).
28. W.F. Kean, F. Forestier, Y. Kassam et al., Sem. Arth. Rheum., 14, 180-186 (1985).
29. R.F. Baggio and S. Baggio, J. Inorg. Nucl. Chem., 35, 3191-3200 (1973).
30. H. Reuben, A. Zalkin, M.O. Faltenns and D.H. Templeton, Inorg. Chem., 13, 1836-1838 (1974).
31. R. Bau, J. Am. Chem. Soc., 120, 9380-9381 (1998).
32. R.V. Parish and S.M. Cottrill, Gold Bull., 20, 3-12 (1987).
33. D.T. Walz, M.J. Di Martino and B.M. Sutton, Med. Chem., Ser. Monogr., 13, 209-244 (1974).
34. M.J. Lefevre, Rev. Belge Homoeopath., 26, 75-84 (1974).
35. M.J. Borigini and H.E. Paulus, in Treatment of the Rheumatic Disease: Companion to the Textbook of Rheumatology, M.H. Weisman and M.E. Weinblatt (Eds) W.B. Saunders, Philadelphia, 1995.
36. D.T. Walz, M.J. DiMartino and D.E. Griswold, Scand. J. Rheumatol., 51 (Suppl.), 16-25 (1984).
37. D.T. Hill and B.M. Sutton, Cryst. Struct. Commun., 9, 679-686 (1980).
38. C.F. Shaw, III, Chem. Rev., 99, 2589-2600 (1999).
39. R. Eisler, Inflamm. Res., 52, 487-501 (2003).
40. C.F. Shaw III, A.A. Isab, J.D. Hoeschele et al., J. Am. Chem. Soc., 116, 2254-2260 (1994).
41. W.E. Smith and J. Reglinski, Persp. Bioinorg. Chem., 1, 183-208 (1991).
42. W.E. Smith, J. Reglinski, S. Hoey et al., Inorg. Chem., 29, 5190-5196 (1990).
43. R.M. Snyder, C. Mirabelli and S.J. Crooke, Biochem. Pharmacol., 35, 923-932 (1986).
44. R. Rudkowski, G.G. Graham, G.D. Champion and J.B. Ziegler, Biochem. Pharmacol., 11, 1687-1695 (1990).
45. G.G. Graham and M.M. Dale, Biochem. Pharmacol., 11, 1697-1702 (1990).
46. G.G. Graham, G.D. Champion and J.B. Ziegler, Metal-Based Drugs, 1, 395-404 (1994).
47. E.R.T. Tiekink and M.W. Whitehouse, in Handbook of Metal-Ligand Interactions in Biological Fluids, Vol. 2, Marcel Dekker, New York, 1266-1273 (1995).
48. D.J. Porter and H.J. Bright, J. Biol. Chem., 262, 9154-9159 (1987).
49. P.D. Cookson, E.R.T. Tiekink and M.W. Whitehouse, Aust. J. Chem., 47, 577-586 (1994).
50. M.W. Whitehouse, P.D. Cookson, G. Siasios and E.R.T. Tiekink, Metal-Based Drugs, 5, 245-249 (1998).
51. E.R.T. Tiekink, Gold Bull., 36, 117-124 (2003).
52. J.F. Fries, D. Bloch, P. Spitz and D.M. Mitchell, Am. J. Med., 78 (Suppl. A), 56-59 (1985).
53. F. Balkwill and A. Mantovani, Lancet, 357, 539-545 (2001).
54. I. Lorenzen, Ann. Clin. Res., 7, 195-201 (1975).
55. J.R. Ward, Am. J. Med., 85 (Suppl. A), 39-44 (1988).
56. C.K. Mirabelli, R.K. Johnson, D.T. Hill et al., J. Med. Chem., 26, 218-223 (1986).
57. E.R.T. Tiekink, Crit. Rev. Oncol. Hematol., 42, 225-248 (2002).
58. T.M. Simon, D.H. Kunishima, G.J. Vibert and A. Lorber, Cancer, 44, 1865-1975 (1979).
59. T.M. Simon, D.H. Kunishima, G.J. Vibert and A. Lorber, Cancer Res., 41, 94-97 (1981).
60. T. Giraldi, G. Sava, L. Perissin and S. Zorzet, Anticancer Res., 4, 221-224 (1984).
61. T. Koide, T. Kojima and H. Kamei, Cancer Biother. Radiopharm., 13, 189-192 (1998).
62. C.K. Mirabelli, R.K. Johnson, C.-M. Sung et al., Cancer Res., 45, 32-39 (1985).
63. S.J. Berners-Price and P.J. Sadler, Struct. Bonding, 70, 27-102 (1988).
64. S.J. Berners-Price, C.K. Mirabelli, R.K. Johnson et al., Cancer Res., 46, 5486-5493 (1986).
65. S.J. Berners-Price, G.R. Girard, D.T. Hill et al., J. Med. Chem., 33, 1386-1392 (1990).
66. S.J. Berners-Price, M.A. Mazid and P.J. Sadler, J. Chem. Soc., Dalton Trans., 969-974 (1984).
67. G.D. Hoke, R.A. Macia, P.C. Meunier et al., Toxicol. Appl. Pharmacol., 100, 293-306 (1989).
68. M.J. McKeage, L. Maharaj and S.J. Berners-Price, Coord. Chem. Rev., 232, 127-135 (2002).
69. M.J. McKeage, Brit. J. Pharmacol., 136, 1081-1082 (2002).
70. M.P. Rigobello, G. Scutari, R. Boscolo and A. Bindoli, Brit. J. Pharmacol., 136, 1162-1168 (2002).
71. E.R.T. Tiekink, Bioinorg. Chem. Appl., 1, 53-67 (2003).
72. E.R.T. Tiekink, P.D. Cookson, B.M. Linahan and L.K. Webster, Metal-Based Drugs, 1, 299-304 (1994).
73. L.K. Webster, S. Rainone, E. Horn and E.R.T. Tiekink, Metal-Based Drugs, 3, 63-66 (1996).
74. D. Crump, G. Siasios and E.R.T. Tiekink, Metal-Based Drugs, 6, 361-368 (1999).
75. D. de Vos, P. Clements, S.M. Pyke et al., Metal-Based Drugs, 6, 31-40 (1999).
76. D. de Vos, D.R. Smyth and E.R.T. Tiekink, Metal-Based Drugs, 8, 303-306 (2001).
77. D. de Vos, S.Y. Ho and E.R.T. Tiekink, Bioinorg. Chem. Appl., 2, 141-154 (2004).
78. S.Y. Ho, Ph.D. Dissertation, National University of Singapore (2004).
79. P.J. Barnard, M.V. Baker, S.J. Berners-Price et al., Dalton Trans., 1038-1047 (2004).
80. R.V. Parish, Metal-Based Drugs, 6, 271-276 (1999).
81. R.C. Elder and M.K. Eidsness, Chem. Rev., 87, 1027-1046 (1987).
82. C.F. Shaw III, M.P. Cancro, P.L. Witkiewicz and J.E. Eldridge, Inorg. Chem., 19, 3198-3201 (1980).
83. D. Schuhmann, M. Muranyi, J. Mirtcheva et al., J. Immunol., 145, 2132-2139 (1990).
84. K. Takahashi, P. Griem, C. Goebel et al., Arthritis Rheum., 35, 483-496 (1994).
85. C.F. Shaw III, S. Schraa, E. Gleichmann et al., Metal-Based Drugs, 1, 351-362 (1994).
86. A. Moustatih and A. Garnier-Suillerot, J. Med. Chem., 32, 1426-1431 (1989).
87. R.G. Buckley, A.M. Elsome, S.P. Fricker et al., J. Med. Chem., 39, 5208-5214 (1996).
88. G. Marcon, S. Carotti, M. Coronnello et al., J. Med. Chem., 45, 1672-1677 (2002).
89. S.J. Berners-Price, R.K. Johnson, A.J. Giovenella et al., J. Inorg. Biochem., 33, 285-295 (1988).
90. K. Nomiya, R. Noguchi, K. Ohsawa et al., J. Inorg. Biochem., 78, 363-370 (2000).
91. K. Nomiya, S. Yamamoto, R. Noguchi et al., J. Inorg. Biochem., 95, 208-220 (2003).
92. C.H.A. Goss, W. Henderson, A.L. Wilkins and C. Evans, J. Organomet. Chem., 679, 194-201 (2003).
93. N. Wasi, H.B. Singh, A. Gajanana and A.N. Raichowdhary, Inorg. Chim. Acta, 135, 133-137 (1987).
94. M. Navarro, H. Perez and R.A. Sanchez-Delgado, J. Med. Chem., 40, 1937-1939 (1997).
95. M. Navarro, E.J. Cisneros-Fajardo, T. Lehmann et al., Inorg. Chem., 40, 6879-6884 (2001).
96. M. Muranaka, T. Miyamoto, T. Shida et al., Ann. Allegy, 40, 132-137 (1978).
97. M. Adachi, H. Sato and T. Takahashi, Ther. Res., 5, 796-803 (1986).
98. A.C. Falcao, M.J. Rocha, A.M. Almeida and M.M. Caramona, J. Clin. Pharma. Ther., 25, 191-195 (2000).
99. D.L. Shapiro and J.R. Masci, J. Rheumatol., 23, 1818-1820 (1996).
100. K. Tepperman, Y. Shinyu, P.W. Roy et al., Metal-Based Drugs, 1, 433-444 (1994).
101. T. Okada, B.K. Patterson, S.-Q. Ye and M.E. Gurney, Virology, 192, 631-642 (1993).